SLS Competitors & Alternatives
Compare Sellas Life Sciences Group Inc with similar stocks in the same industry
Biotechnology
SLS
Main Stock$8.42
Tradestie Score
59
Market Cap
$211.22M
Revenue Growth
-0.8%
Analyst Upside
+286.0%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$30.25
|
$1.84B | - | 48 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$31.83
|
$1.81B | - | 48 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$12.18
|
$1.78B | - | 52 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$18.16
|
$1.78B | - | 39 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$127.14
|
$1.77B | - | 57 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$31.44
|
$1.74B | - | 43 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$30.47
|
$1.68B | - | 47 | Compare |
|
MNKD
Mannkind Corporation
|
$4.22
|
$1.65B | - | 37 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$46.96
|
$1.63B | 5.8 | 40 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.20
|
$1.57B | - | 42 | Compare |
More SLS Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry